|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/14 | |
| C07D 413/14 | |||
| C07D 401/10 | |||
| C07D 401/12 | |||
| C07D 403/10 | |||
| C07D 403/14 | |||
| C07D 417/14 | |||
| C07D 471/04 | |||
| A61P 3/10 | |||
| A61P 9/00 | |||
| A61P 35/00 | |||
| A61P 29/00 | |||
| A61K 31/4725 | |||
| A61K 31/455 | |||
| A61K 31/496 |
| (11) | Patento numeris | 3033336 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14755117.0 |
| Europos patento paraiškos padavimo data | 2014-08-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-06-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-05-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2014/052510 |
| Data | 2014-08-14 |
| (87) | Numeris | WO 2015/022546 |
| Data | 2015-02-19 |
| (30) | Numeris | Data | Šalis |
| 201361865732 P | 2013-08-14 | US | |
| 201361865756 P | 2013-08-14 | US |
| (72) |
EDWARDS, Hannah Joy, GB
EVANS, David Michael, GB
MEGHANI, Premji, GB
NOVAK, Andrew Richard, GB
|
| (73) |
Kalvista Pharmaceuticals Limited,
Porton Down, Salisbury, SP4 0JQ,
GB
|
| (54) | INHIBITORS OF PLASMA KALLIKREIN |
| INHIBITORS OF PLASMA KALLIKREIN |